Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Álvarez N, Herraez B, Fernandez V, Núñez-Torres R, Osorio A, Valcich J, Li M, Törngren T, Harrington PA, Baynes Cet al.(2021) Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women N Engl J Med(in press) DOI 10.1056/NEJMoa1913948, PubMed 33471991
Kyte JA, Andresen NK, Russnes HG, Fretland SØ, Falk RS, Lingjærde OC, Naume B(2020) ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer J Transl Med, 18(1), 269 DOI 10.1186/s12967-020-02421-w, PubMed 32620163
Russnes HG(2020) Clinical trials in the era of precision cancer medicine - for the few or for the many? Acta Oncol, 59(7), 731-732 DOI 10.1080/0284186X.2020.1777582, PubMed 32579040